Why the study?
Does intravenous streptokinase reduce the occurrence of ventricular late potentials in patients with a first acute myocardial infarction?
Population
115 patients admitted with a first acute myocardial infarction
Comparison
Intravenous streptokinase vs Conservative treatment
Design
Cohort
Authors
Loading...
Streptokinase was associated with fewer late potentials; hypothesis-generating for thrombolysis effects on substrate but should not yet change practice.
Does intravenous streptokinase reduce the occurrence of ventricular late potentials in patients with a first acute myocardial infarction?
Intravenous streptokinase significantly reduces the occurrence of ventricular late potentials in patients with a first acute myocardial infarction, and the absence of these potentials is a good non-invasive predictor of infarct-related artery patency.
Chew et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: